Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa H Lancaster

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 9, 2017
A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary FibrosisJoseph M Parker, Ian N Glaspole, Lisa H Lancaster, et al.
Chest|November 26, 2018
Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary FibrosisSteven D Nathan, Ulrich Costabel, Ian Glaspole, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2008
Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injuryStavros Garantziotis, Enrique Zudaire, Carol S Trempus, et al.
Annals of the American Thoracic Society|March 19, 2021
A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary FibrosisTimothy S Blackwell, Justin C Hewlett, Wendi R Mason, et al.
BMJ Open Respiratory Research|July 7, 2020
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO RegistryLaurie D Snyder, Christopher Mosher, Colin H Holtze, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2019
Patient Registries in Idiopathic Pulmonary FibrosisDaniel A Culver, Jürgen Behr, John A Belperio, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Plos One|November 23, 2013
Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung diseaseJonathan A Kropski, Jason M Pritchett, Wendi R Mason, et al.
Cancer Treatment Reviews|April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and managementSandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Viral infection in acute exacerbation of idiopathic pulmonary fibrosisSharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory and Critical Care Medicine|August 9, 2017
A Phase 2 Randomized Controlled Study of Tralokinumab in Subjects with Idiopathic Pulmonary FibrosisJoseph M Parker, Ian N Glaspole, Lisa H Lancaster, et al.
Chest|November 26, 2018
Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary FibrosisSteven D Nathan, Ulrich Costabel, Ian Glaspole, et al.
American Journal of Respiratory and Critical Care Medicine|August 16, 2008
Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injuryStavros Garantziotis, Enrique Zudaire, Carol S Trempus, et al.
Annals of the American Thoracic Society|March 19, 2021
A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary FibrosisTimothy S Blackwell, Justin C Hewlett, Wendi R Mason, et al.
BMJ Open Respiratory Research|July 7, 2020
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO RegistryLaurie D Snyder, Christopher Mosher, Colin H Holtze, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2019
Patient Registries in Idiopathic Pulmonary FibrosisDaniel A Culver, Jürgen Behr, John A Belperio, et al.
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Plos One|November 23, 2013
Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung diseaseJonathan A Kropski, Jason M Pritchett, Wendi R Mason, et al.
Cancer Treatment Reviews|April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and managementSandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Viral infection in acute exacerbation of idiopathic pulmonary fibrosisSharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh, et al.
Pageof 4